Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesdopetam Phase 2a in PD Dyskinesia
NCT03368170Phase 2Completed
- Sponsor
- IRLAB
- Start
- Apr 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of mesdopetam in levodopa-induced dyskinesia (LID), sponsored by IRLAB. Started Apr 2018; status: completed.
02
Drugs
mesdopetam
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT03368170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03368170.